FINWIRES · TerminalLIVE
FINWIRES

Ventia Services Group 獲得維多利亞州格蘭屏山脈和東部都會區的道路維護合約

By

-- 根據週二提交給澳大利亞和紐西蘭證券交易所的文件,Ventia Services Group(澳交所代碼:VNT,新西蘭證券交易所代碼:VNT)已獲得維多利亞州交通與規劃部的新合同,將根據維多利亞州道路維護合同模式,在格蘭屏地區和東部都市區提供道路維護服務。 文件顯示,這些合約的總價值約為3.4億澳元,基本期限為四年,涵蓋日常維護、計畫維護項目和小型基礎建設工程,具體內容取決於政府預算審批和道路優先事項。 文件也指出,這些協議也提供了格蘭屏地區最多兩年、東部都會區最多四年的延期選擇權。 文件補充道,該公司將從7月1日起,為鄉村和都市幹道提供全面的道路網路服務,包括道路檢查、隱患和缺陷整改、緊急應變和小型基建工程。 在週二的交易中,該公司在澳洲和紐西蘭交易所的股票分別上漲了約 5% 和 2%。

Related Articles

Asia

Telix Pharmaceuticals' Investigational Imaging Agent May Potentially Diagnose a Range of Kidney Cancers

Telix Pharmaceuticals' (ASX:TLX) investigational imaging agent TLX250-Px has the potential to help diagnose kidney cancers beyond just clear cell renal cell carcinoma, or ccRCC, the company said Tuesday, citing an independent analysis published in the European Urology scientific journal.The analysis of phase three trial data showed that positive PET scan findings were "highly predictive" of malignancy overall, including in non-clear cell renal cell carcinoma, with a reported positive predictive value of 98%, the company said."Essentially all false-positives for ccRCC in the ZIRCON study have now been shown to be other malignant kidney cancer subtypes, reducing the risk of overtreatment and further supporting clinical adoption," said Telix Group Chief Medical Officer David Cade.

$ASX:TLX
Asia

Huajin International Chairman, CEO Face Consumption Restriction Order

Huajin International (HKG:2738) said its chairman and chief executive were subject to a consumption restriction order due to the alleged nonpayment of amounts owed, according to a Hong Kong bourse filing Tuesday.The company's chairman Xu Songqing and chief executive Chen Chunniu have been subject to the consumption restriction order, effective Nov. 25.The case stems from the alleged non-payment of 130 million yuan by two of the company's units Jiangmen Huamu Metals and Jiangmen Huajin Metal Product, under a finance lease arrangement. As of April 30, 16.4 million yuan was still owed to the creditors.Both Xu and Chen have been negotiating with creditors to resolve the matter and the company expects to reach a settlement by the end of August.

$HKG:2738
Asia

Tata Chemicals' Consolidated Loss Widens in Fiscal Q4

Tata Chemicals' (NSE:TATACHEM, BOM:500770) consolidated attributable loss widened to 21.3 billion Indian rupees in the fiscal fourth quarter ended March 31, from a loss of 1.56 billion rupees a year ago.Loss per share grew to 83.68 rupees compared with a loss per share of 2.19 rupees a year earlier, the chemicals manufacturer said in a filing to the Indian bourses on Monday.Revenue from operations in fiscal Q4 declined to 34.4 billion rupees from 35.1 billion rupees a year ago. This was lower than the 34.8 billion rupees estimated by analysts polled by Visible Alpha.The company's board recommended a dividend of 11 rupees per share for the financial year ended March 31.

$BOM:500770$NSE:TATACHEM